DNA Damage Response Mediated through BRCA1.
- Author:
Eun Ryoung JANG
1
;
Jong Soo LEE
Author Information
1. Research Institute, National Cancer Center, Goyang, Gyeonggi, Korea. leejs@ncc.re.kr
- Publication Type:Review
- MeSH:
Breast;
Breast Neoplasms;
Cell Cycle;
Clone Cells;
Diptera;
DNA Damage*;
DNA Repair;
DNA*;
Female;
Genes, BRCA1;
Humans;
Mammals;
Nuclear Proteins;
Ovarian Neoplasms;
Ovary;
Yeasts;
Zebrafish
- From:Cancer Research and Treatment
2004;36(4):214-221
- CountryRepublic of Korea
- Language:English
-
Abstract:
The BRCA1 gene was identified and cloned in 1994 based on its linkage to early onset breast and ovarian cancer syndromes in women. The tumor suppressor, BRCA1 is known as a major player in the DNA damage response. These are evident from its loss, which causes malignant transformation in breast and ovary, and renders cells to become sensitive to a wide variety of DNA damaging agents. Here, we have implications on functional coupling of the pleiotropic roles of BRCA1, including DNA damage signal networking, DNA repair, transcription, and checkpoint of cell cycle, to tumor suppression by examining the molecular mechanisms and functions of BRCA1. The breast cancer susceptibility 1 (BRCA1) gene was identified and mapped to chromosome 17q21 by analyzing families at high risk from breast and ovarian cancer, and was first cloned in 1994 (1). The BRCA1 gene encodes a large nuclear protein that is ubiquitously expressed in a number of tissues. BRCA1 shares little structural resemblance to the majority of other known proteins (Fig. 1). Its ortholog is only found in mammals but not in yeast, fly, worm, or zebra fish, indicating that BRCA1 may come later in evolution and it may have more specialized and tissue-specific functions in mammalian cells. Although a number of studies delineating and deciphering the real biological roles of BRCA1 have accumulated, understanding these BRCA1 unique features still remains to be challengingly elucidated.